CIRCUMVENT CML Wins S&P Global Award as Best New Food Animal Product
CIRCUMVENT CML, a product of Merck Animal Health, has been awarded the Best New Food Animal Product from S&P Global Animal Health. It is the first and only ready-to-use, single-dose intramuscular injectable vaccine against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae and Lawsonia intracellularis in pigs, three weeks of age or older, the company said.
The award marks the sixth straight year for Merck Animal Health to be honored in this category.
“We are proud to continually be recognized as a leader in the animal health industry that brings together innovative solutions from our combined biopharmaceuticals and technology solutions portfolio to shape the future of animal health,” Shannon Kellner, vice president, U.S. Livestock Business, Merck Animal Health, said in a release. “Our people – from research and development to manufacturing to sales – continually strive to help our customers improve the health of their animals and bring efficiencies to their operations. CIRCUMVENT CML is another example of our pioneering science that will help the swine industry do just that.”
With CIRCUMVENT CML, veterinarians and producers have the convenience of vaccinating for three of the most important swine disease concerns, all in one bottle with no mixing or reconstituting, the company explaine. Also, the animals benefit from the three-way protection in one single vaccination.
"Porcine Circovirus Type 2 is one of the most common and economically damaging viruses in the swine industry,” Jamie Lehman, DVM, swine technical services veterinarian, Merck Animal Health, said in a release. “The disease remains an important pathogen of growing pigs worldwide. CIRCUMVENT CML delivers efficacy against three of the most commonly identified swine diseases in one bottle – and in one vaccination. There is currently no other available injectable vaccine that combines these three pathogens in one bottle.”
The company said this product provides several benefits to swine producers, including:
• Reduced injections and reduced pig handling.
• Less waste, reduced shipments of products and reduced refrigeration storage space.
• The trusted antigens used in existing products, CIRCUMVENT PCV-M G2 and PORCILIS Ileitis, are proven products in the industry that for years have protected swine from disease caused by PCV2, Mycoplasma hyopneumoniae and Lawsonia intracellularis.
• The trusted adjuvant used in CIRCUMVENT PCV-M and PORCILIS Ileitis vaccines, Microsol Diluvac Forte, enhances the immune response to the antigens and increases the duration of immunity.
Read More:
CIRCUMVENT CML Vaccine Allows Producers to Do More With Less, Merck Says
